Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 665 composition records across product categories including Raw materials, Food and drug, Laboratory supplies.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of ARGININE in our catalog (epa_cpdat).
Products
665
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 665 composition records across product categories including Raw materials, Food and drug, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Hair strengthening, Anti-static agent, Deodorizer.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: NA
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 6240 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 790 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 3600 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 6240 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.29 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: POWDER, FOR SOLUTION; Potency: 7.07 %w/v
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 25 mg
US
FDA
FDA NDC lists this ingredient in 85 active drug products and 87 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.